MondayJun 18, 2018 2:35 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) in Good Position as Hemp Legalization Efforts Advance

Operations underway on industrial hemp fields in New Brunswick and Oregon United States trending toward national legalization of hemp agriculture Acquisition of 50 percent interest in Cash Crop Today provides successful media and branding resource Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) is pleased to see increasingly favorable prospects for the industrial hemp industry in the United States after the close of “Hemp History Week” (June 4-10) awareness efforts. Although the plant offers no benefit to recreational drug users, it was ensnared in legislative efforts to control its botanical sibling marijuana decades ago. Now, the veil of…

Continue Reading

MondayJun 18, 2018 1:12 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) Platform Makes Cannabis Supply Chain Safe and Reliable

Current cannabis testing system lacks integrity BLOCKStrain platform can be trusted for safety and reliability Planned product integration and strategic partnership with bioceutical company The tide of cannabis legalization washing over America is, as might be expected, posing challenges in a number of areas. One is protecting the public, determining how to best ensure that marijuana in the marketplace is safe to consume. The other is producer protection; how can breeders and growers stop their strains from being ‘faked’? The obvious answer is testing, but the testing system that has germinated as cannabis cultivation spreads may not be up to…

Continue Reading

ThursdayJun 14, 2018 1:35 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appeals to Investors with Slow Burn Rate, Model that Goes Beyond Cannabis Sector

Chris Bunka, CEO of LXRP, in an interview with CFN Media Group, stated that his company’s cash flow is strengthening from licensing and R&D, with technology applicable to other sectors Bunka noted that LXRP’s 71 million share count is kept purposely low relative to others in the category, with its valuation growing by “close to 2,000 percent” over the past several years LXRP’s goal is to slow disease and make cannabis acceptable to the general population Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in…

Continue Reading

ThursdayJun 14, 2018 10:53 am

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is “One to Watch”

Focused on California, the largest legal cannabis market in North America Operates an attractive royalty model that is beneficial for operators and the company Established partnerships with best-in-class operating entities Extensive network provides access to top-tier projects and operators Executive leadership team with 40+ years of combined experience in fund raising, capital management, corporate development, merchant and commercial banking FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages…

Continue Reading

WednesdayJun 13, 2018 12:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on Delivery of Bioactive Substances via Oral Ingestion

Lexaria has its patented DehydraTECH™ nutrient infusion technology This technology has patent protection for cannabidiol and all other non-psychoactive cannabinoids DehydraTECH™ technology provides greater bio-absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a worldwide leader in enhancing the gastro-intestinal delivery of edible cannabinoid products. The company has its patented nutrient infusion technology called DehydraTECH™. This technology significantly improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other beneficial molecules. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has patents granted in the United States and Australia for applications of its…

Continue Reading

WednesdayJun 13, 2018 11:28 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry amid Growing Alternative Medicine Popularity

PreveCeutical moves on recent stock split to boost share appeal Company’s organic therapeutics aim to relieve maladies for patients with diabetes, brain injuries and other conditions Alternative medicines market expected to generate nearly $200 billion in revenues by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) continues working to shore up its share appeal while seeking remedies for a variety of physical ailments through its nature-centric research to help patients with type 2 diabetes and obesity, mild traumatic brain injury, cancer and pervasive pain. PreveCeutical Medical completed a forward stock split last month on the basis of five…

Continue Reading

TuesdayJun 12, 2018 12:39 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces Launch into Beverage Industry

Strategic planning based off of 125 years of combined experience in the beverage industry Significant expected growth in the beverage and cannabis industry as the two join forces Multi-phase product to create a distribution platform for domestic and international markets Creating a sustainable and successful future that provides quality product worldwide The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a company that produces farm-grown, high quality organic medical cannabis using organic craft growing principles, has announced a global strategic launch into the beverage industry.  The company’s senior management has over 125 years of combined experience in the beverage…

Continue Reading

TuesdayJun 12, 2018 12:09 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures California Extraction Deal as New Ontario Clinic Opens

Sunniva’s Sun-Oil Facility in California will provide Farmacy Phactory with distilled oil products Extraction deal is a significant milestone for the company, cements its position as a reliable manufacturer of clean extracted products New clinic opened in Windsor, Ontario, via wholly owned subsidiary Natural Health Services Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis provider, has struck an extraction deal with Farmacy Phactory, a family-run California cannabis farm (http://cnw.fm/uJ63k). Through wholly owned subsidiary CP Logistics, LLC, Sunniva’s Sun-Oil Facility will provide high quality, pure manufactured distilled oil products, including flavored oil formulations for vaporization cartridges. Sunniva will also…

Continue Reading

MondayJun 11, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Set to Capitalize on Growth of Dietary Supplement, Drug Delivery Markets

Two separate market research reports predict 7.0 percent and 2.9 percent CAGR, respectively, in PreveCeutical’s areas of operation PreveCeutical developing Sol-Gel, an innovative medicine delivery platform Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is uniquely positioned to capitalize of the growth of two different markets in which it currently operates: dietary supplements and drug delivery systems. Two separate market research reports indicated recently that these sectors are expected to grow a projected 7.0 percent and 2.9 percent, respectively, over the next five years. In a report published in May, Technavio estimated that the global dietary…

Continue Reading

MondayJun 11, 2018 12:21 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Reaffirms Expectations with Confirmation of Readiness from Health Canada

Sunniva confirms analyst expectations with COR from Health Canada Company and announcement featured in Seeking Alpha article Over one million square feet of cannabis cultivation facilities under construction Grow facilities in California and Canada target 60 million adults Biopharmaceutical company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) now seems set for a place in the sun. The North American provider of cannabis products and services announced on May 29, 2018, that its wholly owned subsidiary, Sunniva Medical Inc. (“SMI”), had received a Confirmation of Readiness (COR) notification from Health Canada. The good news has not gone unnoticed, with one analyst remarking,…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977